170476 ⎘
Assays involving biological materials from specific organisms or of a specific nature from animals; from humans Assays involving receptors, cell surface antigens or cell surface determinants
Cell analysis system, cell analysis program and cell analysis method
#302Method for inhibiting calcification of a smooth muscle cell (SMC)
#303Prevention of tissue ischemia and related methods
#304Methods for treating brain metastasis
#305Methods and Systems for Modulating Hormones and Related Methods, Agents and Compositions
#306Biomarker for mental disorders including cognitive disorders, and method using said biomarker to detect mental disorders including cognitive disorders
#307PSMA-RELATED THERAPIES
#308HLA G-modified cells and methods
#309PEPTIDE MIMOTOPES OF CLAUDIN 18.2 AND USES THEREOF
#31020-HETE receptor (GPR75) antagonists and methods of use
#311TRPC6 involved in glomerulonephritis
#312Anti-GPR20 antibody
#313Method for assessing the efficacy of IMiDs and composition or combination for use in treating IMiD sensitive diseases
#314Cytotoxic T cell response modifiers
#315Assays using arrestin recruitment and unmodified receptors
#316TIM-3 antibody, antigen binding fragment thereof, and medicinal uses thereof
#317High avidity antigen recognizing constructs
#318ISOLATION, DETECTION, DIAGNOSIS AND/OR CHARACTERIZATION OF CIRCULATING TROP-2-POSITIVE CANCER CELLS
#319METHOD FOR PROMOTING WOUND HEALING BY ADMINISTERING A COMPOUND WHICH BINDS LDL-RECEPTOR-RELATED PROTEIN (LRP) LIGAND BINDING DOMAIN
#320Bistable polynucleotide devices for the sensing and quantification of molecular events
#321Use of modulators of CCR5 in the treatment of cancer and cancer metastasis
#322Conditionally Active Biological Proteins
#323COMPOSITIONS AND METHODS UTILIZING LYSOPHOSPHATIDYLCHOLINE SCAFFOLDS
#324COMPOSITION AND METHOD FOR THE DIAGNOSIS AND TREATMENT OF DISEASES ASSOCIATED WITH NEURITE DEGENERATION
#325Biomarkers for diagnosis and management of neuro-immunological diseases
#326Consumable cryopreserved cells transiently overexpressing gene(s) encoding drug transporter protein(s) and/or drug metabolizing enzyme(s)
#327Consumable cryopreserved cells transiently overexpressing gene(s) encoding drug transporter protein(s) and/or drug metabolizing enzyme(s)
#328Methods for using extracellular adenosine inhibitors and adenosine receptor inhibitors to enhance immune response and inflammation
#329Modified cystic fibrosis transmembrane conductance regulator (CFTR) polypeptides with increased stability and uses thereof
#330COMPOSITION AND METHOD FOR MEASURING THALLIUM INFLUX AND EFFLUX
#331COMPOSITIONS AND METHODS FOR DIAGNOSIS AND TREATMENT OF PERVASIVE DEVELOPMENTAL DISORDER
#332Kisspeptin-54 detection by tandem mass spectrometry
#333MATERIALS AND METHODS FOR EVALUATING AND TREATING NEUROMYELITIS OPTICA (NMO)
#334Vaccine composition comprising cyclic peptides, antibodies to the cyclic peptides or an anticancer composition comprising the same
#335Diagnostic assays and kits for detection of folate receptor 1
#336KIT AND METHOD FOR DETERMINING PROSTATE CANCER MALIGNANCY
#337Method for screening antibody using patient-derived tumor spheroids
#338Method for identifying modulators of notch signaling
#339Methods of using T1R hetero-oligomeric taste receptors to screen for compounds which modulate sweet or umami taste signaling
#340Compounds and methods for the detection of TRPV-6 cancers and drug delivery
#341Method of measuring inhibition of phosphatidylcholine export transport and/or formation activity
#342Method of measuring cell-substrate impedance in living cells to identify compounds affecting receptor tyrosine kinase (RTK) activity and pathways for the treatment of cancer
#343COMPOSITION AND METHODS FOR MEASURING ION CHANNEL ACTIVITY IN A CELL
#344Human otic progenitor identification and isolation
#345In vitro method for the prognosis of progression of a cancer and of the outcome in a patient and means for performing said method
#346Method of agglutination immunoassay
#347Lipopeptides for use in treating liver diseases and cardiovascular diseases
#348Analysis of amino acids in body fluid by liquid chromotography-mass spectrometry
#349Methods for capturing, isolation, and targeting of circulating tumor cells and diagnostic and therapeutic applications thereof
#350Modulators of ATP-binding cassette transporters
#351Defective calcium signaling as a tool in autism spectrum disorders
#352Methods for categorizing and treating subjects at risk for pulmonary exacerbation and disease progression
#353Compound that specifically binds to KIR3DL2 for use in the treatment of peripheral T cell lymphoma
#354CELL SURFACE PROSTATE CANCER ANTIGEN FOR DIAGNOSIS
#355Antibody drug conjugates
#356Biosensors for chloride ions
#357Method of isolating circulating tumor cells
#358Monoclonal antibody therapy for pancreas cancer
#359DETECTION OF MEMBRANE PROTEINS
#360Method for producing animal model of preterm birth and animal model of preterm birth produced by the method
#361In vitro methods of detecting heteroligomeric T1R2/T2R3-expressing cells that are potentially sensitive to sweet tastants
#362Anti-Ly6E antibodies and methods of use
#363Cell analysis system, cell analysis program and cell analysis method
#364PREECLAMPSIA BIOMARKERS AND RELATED SYSTEMS AND METHODS
#365Modulators of ATP-binding cassette transporters
#366Configuring a smart home controller
#367Methods for covalently binding a cell surface protein and a ligand
#368Markers capable of distinguishing cell pluripotency and uses thereof
#369OLFR90 specificity and methods of detection
#370TM4SF1 binding proteins and methods of using same
#371Amplifying rare cell surface markers
#372Molecular marker for cancer stem cell
#373COMPOSITIONS AND METHODS FOR THE DIAGNOSIS AND TREATMENT OF AGE-RELATED MACULAR DEGENERATION
#374Method for Assessing and Predicting Efficacy of Breast Cancer Treatment with a Long-Acting Topoisomerase I Inhibitor
#375OMA1 activity assay
#376Antibodies for the treatment of cancers
#377Probiotics strains for treating and/or preventing diarrhea
#378Therapeutic and diagnostic methods for autism spectrum disorders and other conditions
#379Diagnostic methods for neural disorders
#380Method and kit for the diagnosis of colorectal cancer
#381THERAPEUTIC DRUG FOR MALIGNANT TUMORS
#382STABILIZED PEPTIDE FRAGMENTS FROM PROTOCADHERIN FAT1 AS CANCER BIOMARKERS
#383Method of measuring a level of anti-vinculin antibodies in a biological sample
#384ESOPHAGEAL CANCER MARKER AND USE THEREOF
#385RECEPTOR TYROSINE KINASE-LIKE ORPHAN RECEPTOR 1 (ROR1) SINGLE CHAIN FV ANTIBODY FRAGMENT CONJUGATES AND METHODS OF USE THEREOF
#386Cytometric assays
#387Humanized anti-CLL-1 antibodies
#388Expression cassette and host cell for expressing a Vip3-interacting protein
#389Transformed cell lines expressing non-endogenous cell-surface selective guanosine-responsive G-protein coupled receptors
#390Cyst fluid viscosity as a marker for malignancy
#391Systems and methods to predict risk for preterm labor and/or preterm birth
#392ENRICHMENT AND IDENTIFICATION OF FETAL MATERIAL
#393CYTOTOXIC T CELL RESPONSE MODIFIERS
#394Cell lines for screening odorant and aroma receptors
#395METHODS FOR DIAGNOSING, PROGNOSING, OR THERANOSING A CONDITION USING RARE CELLS
#396RECEPTOR-BINDING DOMAINS LIGANDS FOR THE DETECTION, DIAGNOSIS AND TREATMENT OF PANCREATIC CANCER
#397COMPOSITIONS AND METHODS FOR DIAGNOSIS AND TREATMENT OF PERVASIVE DEVELOPMENTAL DISORDER
#398Reagents and Methods for Breast Cancer Detection
#399Antibodies specific for CLL-1
#400ANTI-CD134 (OX40) ANTIBODIES AND USES THEREOF
#401HER2 peptide regents and methods
#402Consumable cryopreserved cells transiently overexpressing gene(s) encoding drug transporter protein(s) and/or drug metabolizing enzyme(s)
#403Consumable cryopreserved cells transiently overexpressing gene(s) encoding drug transporter protein(s) and/or drug metabolizing enzyme(s)
#404Complement split product C4d for the treatment of inflammatory conditions
#405Biomarkers for seizures
#406Selection of agents modulating gastrointestinal pain
#407B7 FAMILY MEMBER zB7H6 AND RELATED COMPOSITIONS AND METHODS
#408Treating hyperammonemia, reducing plasma ammonia with TLR4 antagonists
#409MATERIALS AND METHODS FOR EVALUATING AND TREATING NEUROMYELITIS OPTICA (NMO)
#410METHODS USING AXL AS A BIOMARKER OF EPITHELIAL-TO-MESENCHYMAL TRANSITION
#411ANTI-FGFR ANTIBODIES AND METHODS OF USE
#412Detection and treatment of LRP4-associated neurotransmission disorders
#413Detection of oral microbial virulence factors
#414Immunity to folate receptors
#415Antibodies to MUC16 and methods of use thereof
#416Using phage epitopes to profile the immune response
#417Inhibitors of notch signaling pathway and use thereof in treatment of cancers
#418COMPOSITIONS AND METHODS FOR PROSTATE CANCER ANALYSIS
#419Dual-target antibody targeting VEGFR-2 and DLL4 and pharmaceutical composition including same
#420Anti-GPNMB antibodies and diagnostic uses thereof
#421METHODS OF IDENTIFYING, ISOLATING AND USING ODORANT AND AROMA RECEPTORS
#422Prognosis and monitoring of membranous nephropathy based on the analysis of PLA2R1 epitope profile and spreading
#423THERAPEUTIC AND DIAGNOSTIC TARGET FOR CANCER COMPRISING DLL3 BINDING REAGENTS
#424METHODS AND KITS FOR DETECTING CANCER
#425Cystic fibrosis transmembrane conductance regulator gene mutations
#426Cardiomyocyte-Specific Biological Markers and Uses Thereof
#427Method for inducing differentiation of pluripotent stem cells into germ cells
#428Methods of treating lung cancer by predicting responders to cisplatin-pemetrexed combination therapy
#429GFRalpha1 AS A BIOMARKER FOR CISPLATIN-INDUCED CHEMORESISTANCE AND METASTASIS
#430Methods for monitoring polymorphonuclear myeloid derived suppressor cells
#431Sortilin 1 is a novel inducer of vascular calcification
#432Modulators of ATP-binding cassette transporters
#433Methods and devices for the production and delivery of beneficial factors from adipose-derived stem cells
#434METHOD FOR TREATING HIGH-GRADE GLIOMAS
#435Biomarkers for determining the clinical response to cell therapy
#436Kisspeptin-54 detection by tandem mass spectrometry
#437Isolation, detection, diagnosis and/or characterization of circulating Trop-2-positive cancer cells
#438Anti-folate receptor alpha antibodies and uses thereof
#439T cell receptor-like antibodies specific for a PRAME peptide
#440TOLL-LIKE RECEPTOR 2 BINDING EPITOPE AND BINDING MEMBER THERETO
#441Treatment and Diagnosis of Hereditary Xerocytosis
#442Treatment with an IL-2 based therapy
#443Human monoclonal antibodies specific for glypican-3 and use thereof
#444Antibodies that bind to AXL proteins
#445Antibodies that bind to AXL proteins
#446Cancer cell specific anti-podocalyxin antibody and method for producing same
#447Diagnostic biomarkers and therapeutic targets for pancreatic cancer
#448Anti-MUC16 antibodies
#449Antibodies targeting G-protein coupled receptor and methods of use
#450Composition for inhibiting growth or proliferation of chronic myelogenous leukemia cancer stem cells, and screening method therefor
#451Cell information acquisition method and cell information acquisition device
#452Bispecific antigen-binding molecules that bind MUC16 and CD3, and compositions thereof
#453PROTEIN BIOMARKER PANELS FOR DETECTING COLORECTAL CANCER AND ADVANCED ADENOMA
#454Method of using transmembrane channel-like protein 6 (TMC6) protein to identify substances affecting salty taste
#455ANTIBODIES THAT BIND CELL SURFACE GRP78 AND THEIR USE FOR DETECTION OF CANCER
#456Micro-array devices for capturing cells in blood and methods of their use
#457METHODS AND PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF BONE METASTASES
#458Predictive biomarkers of clinical response to anti-LPS immunoglobulin treatment
#459CANCER MARKER AND THE USE THEREOF
#460Cell line stably expressing Nav1.5 and method of screening therapeutic agent using the cell line
#461KITS FOR INDENTIFYING AND TREATING SUBJECTS RESISTANT TO ACETYL SALICYLIC ACID
#462Methods and Compositions for Personalized Medicine by Point-of-Care Devices for FSH, LH, HCG and BNP
#463Method, kit and biomarker for diagnosing chronic inflammatory demyelinating polyneuropathy
#464Use of anoctamin as a biomarker for radiation biodosimetry
#465SYSTEMS AND METHODS OF SELECTING COMPOUNDS WITH REDUCED RISK OF CARDIOTOXICITY USING CARDIAC SODIUM ION CHANNEL MODELS
#466Biomarkers in Cancer, Methods, and Systems Related Thereto
#467METHODS FOR MONITORING POLYMORPHONUCLEAR MYELOID DERIVED SUPPRESSOR CELLS, AND COMPOSITIONS AND METHODS OF TREATMENT OF CANCER
#468METHOD OF DETECTING OR DIAGNOSING SJOGREN'S SYNDROME BASED ON THE PRESENCE OF AUTO-ANTIBODY AGAINST AQUAPORIN 5
#469Detection method and kit
#470Analysis of genomic DNA, RNA, and proteins in exosomes for diagnosis and theranosis
#471CKAP4-molecular-targeted antitumor agent
#472Systems, methods, and workflows for optogenetics analysis
#473BIOMARKER FOR DIAGNOSIS OF MOYAMOYA DISEASE
#474Inhibition of SEMA3A in the prevention and treatment of ocular hyperpermeability
#475MULTIFUNCTIONAL MAGNETO-POLYMERIC NANOSYSTEMS FOR RAPID TARGETING, ISOLATION, DETECTION AND SIMULTANEOUS IMAGING OF CIRCULATING TUMOR CELLS
#476IMMOBILIZATION OF CELLS OR VIRUS PARTICLES ON PROTEIN STRUCTURES USING A MICROFLUIDIC CHAMBER
#477METHOD OF BLOCKING PERCEPTION OF MALODOR
#478METHOD FOR SIMULTANEOUSLY ANALYZING BLOOD CELLS HAVING INTERACTIVE MOLECULES
#479Diagnostic assays and kits for detection of folate receptor 1
#480ANTI-MESOTHELIN ANTIBODIES AND USES THEREOF
#481Screening method for pain suppressor and pharmaceutical composition for prevention or treatment of pain
#482Method of measuring cell-substrate impedance in living cells to identify compounds affecting receptor tyrosine kinase (RTK) activity and pathways
#483Methods of detecting T1R hetero-oligomeric taste receptor expression to identify cells that are potentially sensitive to sweet tastants
#484Antibodies directed to membrane transporter NaP12b (SLC34A2) and uses thereof in cancer therapy
#485TEM-1 diagnostic antibodies
#486Consumable cryopreserved cells transiently overexpressing gene(s) encoding drug transporter protein(s)
#487Consumable cryopreserved cells transiently overexpressing gene(s) encoding drug transporter protein(s)
#488Collector for detection and reversible capturing of cells from body fluids in vivo
#489Biotinylated and oxidized LDL receptor and advanced glycation end product receptor produced using genetically engineered silkworm
#490Diagnosis and monitoring treatment of prostate cancer
#491Method of diagnosing and monitoring bladder cancer
#492OPTICAL INTERROGATION AND CONTROL OF DYNAMIC BIOLOGICAL FUNCTIONS
#493COMPOSITIONS AND METHODS FOR TREATING NEURODEGENERATIVE DISEASE
#494Biomarkers for seizures
#495Methods and compositions for single chain variable region ENOX2 antibodies for cancer detection and diagnosis
#496Cancer-related extracellular matrix signatures and related methods and products
#497Inhibitors of cell adhesion
#498Bak binding proteins
#499Reduction in CPC taste aversion by reducing CPC activation of TRPA1, TPRV1, or both
#500METHOD FOR SCREENING COMPOUND SPECIFICALLY SUPPRESSING FORMATION OF CAVEOLAE OF CANCER CELLS, SCREENING KIT, VECTOR AND TRANSFORMANT TO BE USED IN KIT, AND METHOD FOR SELECTING PATIENT FOR WHOM MOLECULARLY TARGETED DRUG IS INDICATED
#501Methods For The Diagnosis Or Prognosis of Breast Cancer
#502PREDICTING TUMOR RESPONSES TO ANTIBODIES AGAINST HEPATOCYTE GROWTH FACTOR (HGF) AND/OR ITS COGNATE RECEPTOR, C-MET
#503Methods of evaluating patients using E-cadherin or vimentin
#504Compound that specifically binds to KIR3DL2 for use in the treatment of peripheral T cell lymphoma
#505Method for assessing the efficacy of IMiDs and composition or combination for use in treating IMiD sensitive diseases
#506HLA G-modified cells and methods
#507Glypican-3 antibody and uses thereof
#508METHODS FOR DIAGNOSIS, PROGNOSIS AND METHODS OF TREATMENT
#509Methods for identifying a receptor for a ligand and uses thereof
#510Synthesis and composition of amino acid linking groups conjugated to compounds used for the targeted imaging of tumors
#511Renal cell populations and uses thereof
#512Methods and kits for measuring von Willebrand factor
#513Method of measuring inhibition of phosphatidylcholine export transport and/or formation activity
#514Feline bitter taste receptors and methods
#515ISOLATED ANTI-MESOTHELIN ANTIBODIES, CONJUGATES AND USES THEREOF
#516Method of Treating Ovarian and Renal Cancer Using Antibodies Against T Cell Immunoglobulin Domain and Mucin Domain 1 (TIM-1) Antigen
#517Glypican-3-specific T-cell receptors and their uses for immunotherapy of hepatocellular carcinoma
#518METHODS OF TREATING CANCER BY TARGETING TUMOR-ASSOCIATED MACROPHAGES
#519Cell Surface Display, Screening and Production of Proteins of Interest
#520Methods of inhibiting pathological angiogenesis with doppel-targeting molecules
#521COMBINED USE OF A TRKA INHIBITOR AND AN EPHA2 INHIBITOR FOR USING IN THE TREATMENT OF SOLID CANCERS, AND METHOD FOR THE PROGNOSIS OF SURVIVAL OF A PATIENT WHO HAS A SOLID CANCER
#522Methods for treating brain metastasis
#523Method for detecting and purifying pancreatic beta cells
#524Target of VGSC β3 protein for prevention, treatment and diagnostic detection of cancers
#525Corneal endothelial cell marker
#526Biomarkers for diagnosis and management of neuro-immunological diseases
#527Diagnosis and treatment of breast cancer
#528Diagnostic method for distinguishing forms of esophageal eosinophilia
#529Use Of Modulators Of CCR5 In The Treatment Of Cancer And Cancer Metastasis
#530Use of SUSD2 protein as marker
#531Treatment of Leukemias and Chronic Myeloproliferative Diseases with Antibodies to EphA3
#532Methods of using TIR hetero-oligomeric receptors for screening compounds that modulate sweet or umami taste
#533PSMA-based molecular-genetic reporter system
#534Capped and conjugated quantum dots
#535Selected reaction monitoring assays
#536MONOCLONAL ANTIBODY THERAPY FOR PANCREAS CANCER
#537METHOD FOR EVALUATING QUALITY OF HUMAN MESENCHYMAL STEM CELL, AND MONOCLONAL ANTIBODY FOR USE IN SAID METHOD
#538Senescent cell biomarkers
#539Conditionally active biological proteins
#540Monoclonal antibodies that specifically block biological activity of a tumor antigen
#541COMPOSITIONS AND METHODS FOR AUTOIMMUNE DISEASE
#542Methods of inhibiting pathological angiogenesis with doppel-targeting molecules
#543NEUROTOXICITY BIOMARKERS FOR DIAGNOSIS AND TREATMENT OF ACUTE TRAUMATIC BRAIN AND SPINAL CORD INJURY
#544Kisspeptin-54 detection by tandem mass spectrometry
#545Method of diagnosing and monitoring bladder cancer and melanoma
#546METHODS OF TREATING MELANOMA
#547Crossmatching blood samples
#548Methods and systems for predicting drug-response
#549Radiolabeled cannabinoid receptor 2 ligand
#550A NEW BIOMARKER OF CHRONIC ALLOGRAFT NEPHROPATHY AND OF RENAL TRANSPLANT REJECTION
#551USE OF 7-CHLORO-N,N,5-TRIMETHYL-4-OXO-3-PHENYL-3,5-DIHYDRO-4H-PYRIDAZINO[4,5-B] INDOLE-1-ACETAMIDE AS A BIOMARKER OF PERIPHERAL BENZODIAZEPINE RECEPTOR LEVELS
#552In vitro assays for assessing cell aging
#553Diagnosis and treatment of cancer using anti-desmoglein-3 antibodies
#554STING AGONISTS AND METHODS OF SELECTING STING AGONISTS
#555Dendritic cell immune receptor activator, method for activating dendritic cell immune receptor, osteoclast formation inhibitor, method for inhibiting osteoclast formation, dendritic cell differentiation/proliferation inhibitor, method for inhibiting dendritic cell differentiation/proliferation, cytokine production inhibitor, method for inhibiting cytokine production, therapeutic method and screening method
#556Markers of the male urogenital tract
#557Di-isopropyl-phosphinoyl-alkanes as topical agents for the treatment of sensory discomfort
#558METHODS, ASSAYS, AND SYSTEMS RELATING TO SAKT
#559Biomarker detection methods and systems and kits for practicing same
#560FOLATE-CONJUGATES AND CORRESPONDING METAL-CHELATE COMPLEXES FOR USE IN DIAGNOSTIC IMAGING AND RADIOTHERAPY
#561Circulating KIM-1 levels for detection of pathologies associated with injury to, or cancer of, the kidney
#562Antibodies against HPA-1a
#563Methods for treatment of gastric cancer
#564Detoxification of microbial virulence factors in oral cavity
#565Diagnostic methods for neural disorders
#566G-protein-coupled-receptor-22-transformed cell lines and methods of use thereof to identify binding compounds
#567SPECIFIC MODULATORS OF CONNEXIN HEMICHANNELS
#568TEM8 ANTIBODIES AND METHODS OF USE
#569METHOD FOR INCREASING THE SENSITIVITY OF IMMUNOASSAY SYSTEM THROUGH PRETREATMENT OF URINE WITH DENATURANT
#570Heteroaryl derivatives as CFTR modulators
#571METHODS FOR DIAGNOSING, PROGNOSING, OR THERANOSING A CONDITION USING RARE CELLS
#572Nucleic Acid Amplification With Integrated Multiplex Detection
#573Compositions and methods for modulating dysferlin expression
#574POTENTIATOR-CORRECTOR COMBINATIONS USEFUL IN THE TREATMENT OF CYSTIC FIBROSIS
#575Polymersome encapsulation of hydrophobic fluorescent polymers
#576PRIMITIVE AND PROXIMAL HEPATIC STEM CELLS
#577Diagnostic and prognostic markers for cancer
#578Methods of propagating rhinovirus C in previously unsusceptible cell lines
#579Compositions and methods utilizing lysophosphatidylcholine scaffolds
#580COMPOSITION AND METHOD FOR MEASURING THALLIUM INFLUX AND EFFLUX
#581Esophageal cancer marker and use thereof
#582In vitro diagnostic and prognosis of major adverse events in patients undergoing coronary angiography
#583Analysis of genomic DNA, RNA, and proteins in exosomes for diagnosis and theranosis
#584Therapies for Cancer Using RLIP76
#585Anti-Ly6E antibodies and methods of use
#586Vip3 Interacting Polypeptides and Methods for Identifying Insecticidal Agents
#587Method of isolating a target cell
#588CANCER-RELATED EXTRACELLULAR MATRIX SIGNATURES AND RELATED METHODS AND PRODUCTS
#589Therapeutic drug for malignant tumors
#590APPLICATION OF INDUCED PLURIPOTENT STEM CELLS TO GENERATE ADOPTIVE CELL THERAPY PRODUCTS
#591Antibody-drug conjugates with high drug loading
#592ELISA for a Naturally-Occurring Soluble Truncated Form of IL-23 Receptor
#593Systems and methods for the monitoring of protein complex formation in cells
#594MARKER OF NEUROPATHIC GAUCHER'S DISEASE AND METHODS OF USE THEREOF
#595Quantifying FR-α and GART proteins for optimal cancer therapy
#596Methods and compositions for single chain variable region ENOX2 antibodies for cancer detection and diagnosis
#597Methods for single chain variable region ENOX2 antibodies for cancer detection and diagnosis
#598S100P AND HYALURONIC ACID AS BIOMARKERS FOR METASTATIC BREAST CANCER
#599Tagged ligands for enrichment of rare analytes from a mixed sample
#600High MAST2-affinity polypeptides and uses thereof